List of Tables
Table 1. Global Insulin Drugs for Diabetes Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Insulin Drugs for Diabetes Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Insulin Drugs for Diabetes Market Competitive Situation by Manufacturers in 2025
Table 4. Global Insulin Drugs for Diabetes Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Insulin Drugs for Diabetes Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Insulin Drugs for Diabetes Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Insulin Drugs for Diabetes Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Insulin Drugs for Diabetes Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Insulin Drugs for Diabetes, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Insulin Drugs for Diabetes, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Insulin Drugs for Diabetes, Product Types and Applications
Table 12. Global Key Manufacturers of Insulin Drugs for Diabetes, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin Drugs for Diabetes Companies by Tier (Tier 1, Tier 2, Tier 3), based on Insulin Drugs for Diabetes Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Insulin Drugs for Diabetes Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Insulin Drugs for Diabetes Sales by Region (K Units), 2021–2026
Table 18. Global Insulin Drugs for Diabetes Sales Market Share by Region (2021–2026)
Table 19. Global Insulin Drugs for Diabetes Sales by Region (K Units), 2027–2032
Table 20. Global Insulin Drugs for Diabetes Sales Market Share by Region (2027–2032)
Table 21. Global Insulin Drugs for Diabetes Revenue by Region (US$ Million), 2021–2026
Table 22. Global Insulin Drugs for Diabetes Revenue Market Share by Region (2021–2026)
Table 23. Global Insulin Drugs for Diabetes Revenue by Region (US$ Million), 2027–2032
Table 24. Global Insulin Drugs for Diabetes Revenue Market Share by Region (2027–2032)
Table 25. North America Insulin Drugs for Diabetes Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Insulin Drugs for Diabetes Sales by Country (K Units), 2021–2026
Table 27. North America Insulin Drugs for Diabetes Sales by Country (K Units), 2027–2032
Table 28. North America Insulin Drugs for Diabetes Revenue by Country (US$ Million), 2021–2026
Table 29. North America Insulin Drugs for Diabetes Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Insulin Drugs for Diabetes Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Insulin Drugs for Diabetes Sales by Country (K Units), 2021–2026
Table 32. Europe Insulin Drugs for Diabetes Sales by Country (K Units), 2027–2032
Table 33. Europe Insulin Drugs for Diabetes Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Insulin Drugs for Diabetes Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Insulin Drugs for Diabetes Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Insulin Drugs for Diabetes Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Insulin Drugs for Diabetes Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Insulin Drugs for Diabetes Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Insulin Drugs for Diabetes Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Insulin Drugs for Diabetes Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Insulin Drugs for Diabetes Sales by Country (K Units), 2021–2026
Table 42. Latin America Insulin Drugs for Diabetes Sales by Country (K Units), 2027–2032
Table 43. Latin America Insulin Drugs for Diabetes Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Insulin Drugs for Diabetes Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Insulin Drugs for Diabetes Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Insulin Drugs for Diabetes Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Insulin Drugs for Diabetes Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Insulin Drugs for Diabetes Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Insulin Drugs for Diabetes Revenue by Country (US$ Million), 2027–2032
Table 50. Global Insulin Drugs for Diabetes Sales (K Units) by Type (2021–2026)
Table 51. Global Insulin Drugs for Diabetes Sales (K Units) by Type (2027–2032)
Table 52. Global Insulin Drugs for Diabetes Sales Market Share by Type (2021–2026)
Table 53. Global Insulin Drugs for Diabetes Sales Market Share by Type (2027–2032)
Table 54. Global Insulin Drugs for Diabetes Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Insulin Drugs for Diabetes Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Insulin Drugs for Diabetes Revenue Market Share by Type (2021–2026)
Table 57. Global Insulin Drugs for Diabetes Revenue Market Share by Type (2027–2032)
Table 58. Global Insulin Drugs for Diabetes Price (US$/Unit) by Type (2021–2026)
Table 59. Global Insulin Drugs for Diabetes Price (US$/Unit) by Type (2027–2032)
Table 60. Global Insulin Drugs for Diabetes Sales (K Units) by Application (2021–2026)
Table 61. Global Insulin Drugs for Diabetes Sales (K Units) by Application (2027–2032)
Table 62. Global Insulin Drugs for Diabetes Sales Market Share by Application (2021–2026)
Table 63. Global Insulin Drugs for Diabetes Sales Market Share by Application (2027–2032)
Table 64. Global Insulin Drugs for Diabetes Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Insulin Drugs for Diabetes Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Insulin Drugs for Diabetes Revenue Market Share by Application (2021–2026)
Table 67. Global Insulin Drugs for Diabetes Revenue Market Share by Application (2027–2032)
Table 68. Global Insulin Drugs for Diabetes Price (US$/Unit) by Application (2021–2026)
Table 69. Global Insulin Drugs for Diabetes Price (US$/Unit) by Application (2027–2032)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Insulin Drugs for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novo Nordisk Insulin Drugs for Diabetes Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Insulin Drugs for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Sanofi Insulin Drugs for Diabetes Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Eli Lilly Company Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Insulin Drugs for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Eli Lilly Insulin Drugs for Diabetes Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Insulin Drugs for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Novartis Insulin Drugs for Diabetes Product
Table 89. Novartis Recent Developments/Updates
Table 90. Merck Company Information
Table 91. Merck Description and Business Overview
Table 92. Merck Insulin Drugs for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Merck Insulin Drugs for Diabetes Product
Table 94. Merck Recent Developments/Updates
Table 95. AstraZeneca Company Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca Insulin Drugs for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. AstraZeneca Insulin Drugs for Diabetes Product
Table 99. AstraZeneca Recent Developments/Updates
Table 100. Bayer Company Information
Table 101. Bayer Description and Business Overview
Table 102. Bayer Insulin Drugs for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Bayer Insulin Drugs for Diabetes Product
Table 104. Bayer Recent Developments/Updates
Table 105. Takeda Company Information
Table 106. Takeda Description and Business Overview
Table 107. Takeda Insulin Drugs for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Takeda Insulin Drugs for Diabetes Product
Table 109. Takeda Recent Developments/Updates
Table 110. Johnson & Johnson Company Information
Table 111. Johnson & Johnson Description and Business Overview
Table 112. Johnson & Johnson Insulin Drugs for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Johnson & Johnson Insulin Drugs for Diabetes Product
Table 114. Johnson & Johnson Recent Developments/Updates
Table 115. Tonghua Dongbao Pharmaceutical Company Information
Table 116. Tonghua Dongbao Pharmaceutical Description and Business Overview
Table 117. Tonghua Dongbao Pharmaceutical Insulin Drugs for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Tonghua Dongbao Pharmaceutical Insulin Drugs for Diabetes Product
Table 119. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
Table 120. Wanbang Biopharmaceuticals Company Information
Table 121. Wanbang Biopharmaceuticals Description and Business Overview
Table 122. Wanbang Biopharmaceuticals Insulin Drugs for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Wanbang Biopharmaceuticals Insulin Drugs for Diabetes Product
Table 124. Wanbang Biopharmaceuticals Recent Developments/Updates
Table 125. HTBT Company Information
Table 126. HTBT Description and Business Overview
Table 127. HTBT Insulin Drugs for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. HTBT Insulin Drugs for Diabetes Product
Table 129. HTBT Recent Developments/Updates
Table 130. Gan & Lee Pharmaceuticals Company Information
Table 131. Gan & Lee Pharmaceuticals Description and Business Overview
Table 132. Gan & Lee Pharmaceuticals Insulin Drugs for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Gan & Lee Pharmaceuticals Insulin Drugs for Diabetes Product
Table 134. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 135. Kamp Pharmaceuticals Company Information
Table 136. Kamp Pharmaceuticals Description and Business Overview
Table 137. Kamp Pharmaceuticals Insulin Drugs for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Kamp Pharmaceuticals Insulin Drugs for Diabetes Product
Table 139. Kamp Pharmaceuticals Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Insulin Drugs for Diabetes Distributors List
Table 143. Insulin Drugs for Diabetes Customers List
Table 144. Insulin Drugs for Diabetes Market Trends
Table 145. Insulin Drugs for Diabetes Market Drivers
Table 146. Insulin Drugs for Diabetes Market Challenges
Table 147. Insulin Drugs for Diabetes Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Insulin Drugs for Diabetes
Figure 2. Global Insulin Drugs for Diabetes Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Insulin Drugs for Diabetes Market Share by Type: 2025 & 2032
Figure 4. Rapid-acting Insulin Product Picture
Figure 5. Short-acting Insulin Product Picture
Figure 6. Intermediate-acting Insulin Product Picture
Figure 7. Long-acting Insulin Product Picture
Figure 8. Ultra-long-acting Insulin Product Picture
Figure 9. Global Insulin Drugs for Diabetes Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Insulin Drugs for Diabetes Market Share by Application: 2025 & 2032
Figure 11. Hospital and Clinic
Figure 12. Retail Pharmacies
Figure 13. Other
Figure 14. Global Insulin Drugs for Diabetes Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Insulin Drugs for Diabetes Market Size (US$ Million), 2021–2032
Figure 16. Global Insulin Drugs for Diabetes Sales (K Units), 2021–2032
Figure 17. Global Insulin Drugs for Diabetes Average Price (US$/Unit), 2021–2032
Figure 18. Insulin Drugs for Diabetes Report Years Considered
Figure 19. Insulin Drugs for Diabetes Sales Share by Manufacturers in 2025
Figure 20. Global Insulin Drugs for Diabetes Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Insulin Drugs for Diabetes Players: Market Share by Revenue in Insulin Drugs for Diabetes in 2025
Figure 22. Insulin Drugs for Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Insulin Drugs for Diabetes Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Insulin Drugs for Diabetes Sales Market Share by Country (2021–2032)
Figure 25. North America Insulin Drugs for Diabetes Revenue Market Share by Country (2021–2032)
Figure 26. United States Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Insulin Drugs for Diabetes Sales Market Share by Country (2021–2032)
Figure 29. Europe Insulin Drugs for Diabetes Revenue Market Share by Country (2021–2032)
Figure 30. Germany Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Insulin Drugs for Diabetes Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Insulin Drugs for Diabetes Revenue Market Share by Region (2021–2032)
Figure 37. China Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Insulin Drugs for Diabetes Sales Market Share by Country (2021–2032)
Figure 45. Latin America Insulin Drugs for Diabetes Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Insulin Drugs for Diabetes Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Insulin Drugs for Diabetes Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Insulin Drugs for Diabetes Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Insulin Drugs for Diabetes by Type (2021–2032)
Figure 56. Global Revenue Market Share of Insulin Drugs for Diabetes by Type (2021–2032)
Figure 57. Global Insulin Drugs for Diabetes Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Insulin Drugs for Diabetes by Application (2021–2032)
Figure 59. Global Revenue Market Share of Insulin Drugs for Diabetes by Application (2021–2032)
Figure 60. Global Insulin Drugs for Diabetes Price (US$/Unit) by Application (2021–2032)
Figure 61. Insulin Drugs for Diabetes Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
